The International Hyperhidrosis Society News Blog is the only publication dedicated solely to the needs of hyperhidrosis sufferers, their loved ones, and the physicians and scientists who care for them. Alerts and news are published throughout the year and conveniently delivered to tens of thousands of global subscribers by email. If you haven't already subscribed to this groundbreaking resource from the International Hyperhidrosis Society, sign up today!
A newly-published research article in the Journal of Drugs in Dermatology shows that hyperhidrosis patients wait YEARS (3 to 10 years, in fact) before seeking treatment and that some of the most commonly recommended treatments provide the least satisfaction. Read the full blog to discover all the key findings. Thank-you International Hyperhidrosis Society community for participating in this eye-opening study.
Here’s a story about an “ordinary” person making a difference. Shannon McLinden, founder of Summer Soles and FarmHouse Fresh, is a member of our community (just like you) and she’s using her businesses, her story, and her Texas ranch for positive change. Life with Hh can be hard, but if each of us strives to make a difference… that can make ALL the difference.
It’s been just over a month since our Patient-Focused Drug Development (PFDD) meeting on hyperhidrosis (Hh), but the process is not over. Your – and our -- input will help shape the future of hyperhidrosis care. PFDDs are an important way for us to make our voices and needs heard by treatment developers, healthcare providers, and the U.S. Food and Drug Administration (FDA). Have your say and comment via a “PFDD Comment” email.
This is a watershed moment for hyperhidrosis. The International Hyperhidrosis Society hosted a Patient-Focused Drug Development meeting in Washington, DC on November 13, 2017 designed to ensure that those affected by hyperhidrosis can make their voices – and needs -- heard by treatment developers, healthcare providers, and regulatory professionals from the U.S. Food and Drug Administration (FDA). If you’ve ever wanted a better way to control your sweating – and to stop sweating from controlling your life – it’s time to speak up - OPEN COMMENT PERIOD NEEDS YOUR INPUT NOW.
A new study details just how hard it can be to live with hyperhidrosis and how the condition can negatively impact nearly every aspect of a person’s life. From damaging emotions to not being able to go to the movies – if you’re feeling trapped by sweat, you’re not alone.
With a reach that impacts 99% of the world’s business, and 237,734 employees around the globe, AT&T is an international powerhouse – a powerhouse with a potentially large hyperhidrosis (Hh) population. According to research Hh affects 4.8% of the population, which means that AT&T could have 11,500 employees worldwide dealing with excessive sweating. Helping these employees to perform optimally and to feel valued is part of AT&T’s health and diversity initiatives. Partnering with the International Hyperhidrosis Society (IHhS), AT&T recently added Hh as one of the relatively common medical conditions it recognizes as a disability that can benefit from accommodations at work for employees’ greater comfort, creativity, and productivity.
The American Academy of Dermatology, arguably the world’s most influential dermatology organization, has awarded our co-founder, Dr. David Pariser, with its most prestigious honor — the Gold Medal — and we are not surprised a bit! Discover how Dr. Pariser has been championing hyperhidrosis and dermatologic care for 40 years and how fortunate we are to have his leadership.
